IL2RA and neoplasm: It is quite clear in mice that Tregs suppress tumor-specific effector T cells since mice depleted of Tregs by anti-CD25 antibody or T cell-deficient mice reconstituted only with effector T cells effectively eliminate a variety of syngeneic tumors (37, 38).